Contributions of hippurate, indoxyl sulfate, and o-hydroxyhippurate to impaired ligand binding by plasma in azotemic humans
- 1 December 1987
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 36 (24) , 4215-4220
- https://doi.org/10.1016/0006-2952(87)90661-7
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Isolation and chemical identification of inhibitors of plasma ligand bindingKidney International, 1986
- Suppression of Para-aminohippurate Transport in the Isolated Perfused Kidney by an Inhibitor of Protein Binding in UremiaAmerican Journal of Kidney Diseases, 1984
- Impaired Binding of Drugs and Endogenous Ligands in Renal DiseasesAmerican Journal of Kidney Diseases, 1983
- Decreased drug binding in uraemia: Effect of indoxyl sulphate and other endogenous substances on the binding of drugs and dyes to human albuminBiochemical Pharmacology, 1982
- Suppression of tubular anion transport by an inhibitor of serum protein binding in uremiaKidney International, 1981
- Plasma protein binding in uremia: Extraction and characterization of an inhibitorKidney International, 1980
- Impaired Plasma Phenytoin Binding in UremiaNephron, 1980
- Protein binding of drugs in uremic and normal serum: The role of endogenous binding inhibitorsBiochemical Pharmacology, 1976
- Reduced in vitro binding of tryptophan by plasma in uremiaKidney International, 1974
- INFLUENCE OF DISEASE ON BINDING OF DRUGS TO PLASMA PROTEINS*Annals of the New York Academy of Sciences, 1973